About Bioline  All Journals  Testimonials  Membership  News

Rwanda Medical Journal
Rwanda Health Communication Center - Rwanda Biomedical Center (RHCC - RBC)
ISSN: 2079-097X
EISSN: 2079-097X
Vol. 79, No. 1, 2022, pp. 9-17
Bioline Code: rw22002
Full paper language: English
Document type: Research Article
Document available free of charge

Rwanda Medical Journal, Vol. 79, No. 1, 2022, pp. 9-17

 en Analysis of short-term quality of life in post-surgical androgen deprivation therapy in advanced prostate cancer: a comparison of bilateral sub-capsular orchidectomy and bilateral total orchidectomy
Arogundade, A. K.; Ajape, A. A.; Popoola, A. A.; Abiola, O. O. & Biliaminu, S. A.


INTRODUCTION: The use of Androgen Deprivation Therapy (ADT) in treating advanced prostate cancer poses a host of challenges that can affect the health-related quality of life (HRQoL) of these patients. Previous studies have demonstrated the poor quality of life (QoL) of patients after ADT; however, there is a scarcity of literature that compares HRQoL following bilateral subcapsular orchidectomy (BSCO) and bilateral total orchidectomy (BTO) in sub-Saharan Africa.
This study aimed to compare the HRQoL of patients with advanced prostate cancer following treatment with BSCO and BTO.
METHODS: A randomized, single-blind study concerning 64 patients with advanced prostate cancer; the subjects were randomized into BTO and BSCO treatment groups. The study was conducted over a period of ten months at a tertiary hospital situated in the North-central zone of Nigeria. Structured and validated instruments (FACT-PI and Karnofsky) were used to assess HRQoL during patient follow-up visits over a period of six months to obtain data regarding HRQoL and patient satisfaction. Statistical analysis using a chi-squared test and paired t-test were done to allow the comparison of HRQoL assessment scores and patients’ satisfaction ratings between the two groups.
RESULTS: The mean age of the subjects was 71.63   7.56 years and 70.06   8.79 years for the BTO and BSCO group respectively (p = 0.449).
Also, the mean Gleason’s score was 7.44 vs. 7.31 respectively (p =0.714). Health-Related QoL assessment with FACT-PI and Karnofsky showed significantly better outcomes after BSCO (p < 0.001). Only 17% of the participants had psychological compromise after ADT.
CONCLUSION: The two techniques of orchidectomy differ significantly in their short term QoL response to treatment; BSCO was associated with better patient outcomes compared to BTO.

Advanced Prostate Cancer; Androgen Deprivation Therapy; Subcapsular Orchidectomy; Total Orchidectomy; Quality of Life

© Copyright 2022 - The Author(s)
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil